Literature DB >> 23467236

Dissecting the actions of widely used diabetes drugs.

Roger H Unger1, Eric D Berglund, Joel F Habener, Alan D Cherrington.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23467236     DOI： 10.1038/nm.3123

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  9 in total

1.  Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus.

Authors:  P Shah; A Vella; A Basu; R Basu; W F Schwenk; R A Rizza
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

Review 2.  Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.

Authors:  Roger H Unger; Alan D Cherrington
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

Review 3.  Glucagon and regulation of glucose metabolism.

Authors:  Guoqiang Jiang; Bei B Zhang
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-04       Impact factor: 4.310

Review 4.  Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years.

Authors:  P J Randle
Journal:  Diabetes Metab Rev       Date:  1998-12

5.  Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.

Authors:  Marc Foretz; Sophie Hébrard; Jocelyne Leclerc; Elham Zarrinpashneh; Maud Soty; Gilles Mithieux; Kei Sakamoto; Fabrizio Andreelli; Benoit Viollet
Journal:  J Clin Invest       Date:  2010-06-23       Impact factor: 14.808

Review 6.  Targeting the glucagon receptor family for diabetes and obesity therapy.

Authors:  Young Min Cho; Catherine E Merchant; Timothy J Kieffer
Journal:  Pharmacol Ther       Date:  2012-06-01       Impact factor: 12.310

7.  Role of AMP-activated protein kinase in mechanism of metformin action.

Authors:  G Zhou; R Myers; Y Li; Y Chen; X Shen; J Fenyk-Melody; M Wu; J Ventre; T Doebber; N Fujii; N Musi; M F Hirshman; L J Goodyear; D E Moller
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

8.  The effect of insulin on the alpha-cell response to hyperglycemia in long-standing alloxan diabetes.

Authors:  J T Braaten; G R Faloona; R H Unger
Journal:  J Clin Invest       Date:  1974-04       Impact factor: 14.808

9.  Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP.

Authors:  Russell A Miller; Qingwei Chu; Jianxin Xie; Marc Foretz; Benoit Viollet; Morris J Birnbaum
Journal:  Nature       Date:  2013-01-06       Impact factor: 49.962
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.